OTCMKTS:ITHUF iAnthus Capital - ITHUF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iAnthus Capital Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.03 0.00 (0.00%) (As of 02/2/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.03▼$0.0350-Day Range$0.02▼$0.0552-Week Range$0.02▼$0.20Volume114,886 shsAverage Volume204,131 shsMarket CapitalizationN/AP/E Ratio0.18Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About iAnthus Capital (OTCMKTS:ITHUF) StockiAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.Read More Receive ITHUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address ITHUF Stock News HeadlinesJanuary 18, 2023 | ca.finance.yahoo.comiAnthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida MarketDecember 23, 2022 | fool.comiAnthus Capital (OTC: ITHUF)February 2, 2023 | PressReach (Ad)Stocks Positioned For The YearThis breakthrough stock has bright future this decade.December 20, 2022 | msn.comCannabis Producer Ianthus Capital Explores Options For A Potential Sale Following Rough YearNovember 21, 2022 | finance.yahoo.comiAnthus Provides Update on AGM PetitionNovember 15, 2022 | finance.yahoo.comiAnthus Announces Appointment of Philippe Faraut as CFONovember 9, 2022 | msn.comiAnthus Q3 Revenue Declines 20% YoY, What About Net Loss?October 17, 2022 | msn.comMarijuana Stock Movers For October 17, 2022February 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.October 11, 2022 | msn.comCannabis Stock Movers For October 11, 2022August 29, 2022 | msn.comCannabis Stock Movers For August 29, 2022August 23, 2022 | finance.yahoo.comiAnthus Reports Second Quarter 2022 Financial ResultsAugust 12, 2022 | finance.yahoo.comiAnthus Announces Results of Annual General Meeting of ShareholdersJuly 30, 2022 | morningstar.comiAnthus Capital Holdings Inc Stock Quote ITHUFJune 10, 2022 | benzinga.comiAnthus Gets Massachusetts Regulatory Approval For Recapitalization TransactionJune 10, 2022 | finance.yahoo.comiAnthus Announces Massachusetts Regulatory Approval for Recapitalization TransactionMay 15, 2022 | benzinga.comMcCrory's Sunny Hill Nursery LLCMay 6, 2022 | finance.yahoo.comiAnthus Announces Appointment of Replacement Interim Chief Executive Officer and Director and Provides Update on Recapitalization TransactionMay 4, 2022 | finance.yahoo.comiAnthus Announces Resignation of Co-founder Randy MaslowMarch 18, 2022 | finance.yahoo.comiAnthus Reports Fiscal Fourth Quarter, Full Year 2021 Financial Results and Provides Update on Annual General MeetingFebruary 3, 2022 | benzinga.comiAnthus Closes Acquisition Of New Jersey License HolderJanuary 7, 2022 | finance.yahoo.comiAnthus Provides Update on Retention Measures for EmployeesNovember 12, 2021 | markets.businessinsider.comCBD For Life: Created To Treat Scoliosis Pain, Now Helping Millions Across The CountryNovember 9, 2021 | msn.comiAnthus Reports 21% YoY Revenue Increase And Net Loss Decline In Q3 Despite 2020 ChallengesNovember 8, 2021 | finance.yahoo.comiAnthus Reports Third Quarter 2021 Financial Results and Provides Update on U.S. Class Action Complaint and Complaint Filed by Hi-Med, LLCNovember 4, 2021 | finance.yahoo.comiAnthus Provides Corporate Update and Notice of Florida Regulatory Approval for Recapitalization Transaction Change of OwnershipOctober 13, 2021 | finance.yahoo.comiAnthus Announces Ruling by the Ontario Superior Court of JusticeSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ITHUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address ITHUF Company Calendar Today2/02/2023Next Earnings (Estimated)3/16/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ITHUF CUSIPN/A CIK1643154 Webwww.ianthuscapital.com PhoneN/AFaxN/AEmployees930Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.18 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Robert R. Galvin (Age 61)Interim CEO & COO Comp: $925kMr. Philippe Faraut (Age 53)Chief Financial Officer Ms. Megan W. Kulick CFAVP of Investor RelationsMr. Andrew R. Ryan Esq.Gen. CounselMr. Michael R. WoolstonSr. VP of Manufacturing, Supply Chain & QualityKey Competitors1933 IndustriesOTCMKTS:TGIFF4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFAcreageOTCMKTS:ACRHFView All Competitors ITHUF Stock - Frequently Asked Questions How have ITHUF shares performed in 2023? iAnthus Capital's stock was trading at $0.0230 at the start of the year. Since then, ITHUF stock has increased by 30.4% and is now trading at $0.03. View the best growth stocks for 2023 here. Are investors shorting iAnthus Capital? iAnthus Capital saw a increase in short interest in January. As of January 15th, there was short interest totaling 11,900 shares, an increase of 417.4% from the December 31st total of 2,300 shares. Based on an average trading volume of 439,500 shares, the days-to-cover ratio is presently 0.0 days. View iAnthus Capital's Short Interest. When is iAnthus Capital's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023. View our ITHUF earnings forecast. What is iAnthus Capital's stock symbol? iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF." How do I buy shares of iAnthus Capital? Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iAnthus Capital's stock price today? One share of ITHUF stock can currently be purchased for approximately $0.03. How many employees does iAnthus Capital have? The company employs 930 workers across the globe. This page (OTCMKTS:ITHUF) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.